ONCOSEC MED INC - COM NEW (ONCS)

CUSIP: 68234L207

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
13,636,142
Share change
+9,079,010
Total reported value
$25,635,000
Price per share
$1.88
Number of holders
36
Value change
+$17,321,795
Number of buys
24
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 68234L207?
CUSIP 68234L207 identifies ONCS - ONCOSEC MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOSEC MED INC - COM NEW (ONCS) as of Q1 2018

As of 31 Mar 2018, ONCOSEC MED INC - COM NEW (ONCS) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,636,142 shares. The largest 10 holders included venBio Select Advisor LLC, Point72 Asset Management, L.P., NEXTHERA CAPITAL LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, UBS OCONNOR LLC, Crestline Management, LP, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and NORTHERN TRUST CORP. This page lists 36 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.